|
|
|
| Study on the Therapeutic Efficacy and Serum Tumor Markers Levels of Patients with Ultrasound-guided Interventional Therapy for Ovarian Endometrioid Cyst |
| ZHANG Rui, REN Yongfeng, XU Yanlan, et al |
| Bozhou People's Hospital, Anhui Bozhou 236000, China |
|
|
|
|
Abstract Objective: To investigate the efficacy and serum tumor markers levels of patients with ultrasound-guided interventional therapy for ovarian endometrioid cyst. Methods: A total of 80 patients with ovarian endometrioid cyst admitted to our hospital from May 2019 to May 2022 were randomly divided into two groups: 40 cases in the control group underwent laparoscopic cystectomy, and 40 cases in the study group underwent ultrasound-guided interventional therapy. The clinical efficacy, operation time, antibiotic use time, and hospital stay were compared between the two groups. The serum tumor marker levels and ovarian function indexes were evaluated before and after the operation. The recurrence rate of the two groups was observed one year after operation. Results: The clinical efficacy of the study group was higher than that of the control group (P<0.05). The operation time, antibiotic usage time, and hospitalization time of the study group were shorter than those of the control group (P<0.05). 6 months after the operation, the serum Carbohydra Antigen 125 (CA125),Carbohydra Antigen 199 (CA199) and Human epididymal protein 4 (HE4) levels in the study group were lower than those in the control group (P<0.05). Six months after the operation, estrogen (E2) level in the study group was lower than that in the control group, Follicle Stimulating Hormones (FSH) and Luteinizing Hormones (LH) levels in the study group were higher than those in the control group (P<0.05). The recurrence rate in the study group was lower than that in the control group 1 year after operation (P<0.05). Conclusion: The use of ultrasound-guided invasive puncture in the treatment of patients with adenometrioid cysts of the ovaries can enhance the efficacy and reduce the level of serum tumor markers, improve the function of the ovaries, and reduce the rate of postoperative relapse.
|
|
|
|
|
|
[1] 中国医师协会妇产科医师分会妇科肿瘤学组.卵巢囊肿诊治中国专家共识(2022年版)[J].中国实用妇科与产科杂志,2022,38(8):814-819.
[2] 黄达元,孙莉,陈学红,等.基于无瘤技术自制取物袋在经脐三孔腹腔镜卵巢囊肿剔除术中的应用[J].中国微创外科杂志,2021,21(5):464-466.
[3] 靳冬梅,伍东月,杜瑞亭,等.腹腔镜下卵巢囊肿剔除术中电凝和缝合止血对卵巢储备功能的影响[J].中国现代医学杂志,2022,32(6):18-23.
[4] 吴磊丽,蔡华丽,孙德胜,等.超声引导穿刺硬化术联合地诺孕素治疗卵巢子宫内膜异位囊肿的疗效[J].山东大学学报(医学版),2023,61(6):65-69,78.
[5] 周冬梅,汤云仙,冯冠男,等.CA125、CA199及HE4联合检测对卵巢子宫内膜异位囊肿破裂的诊断[J].中南民族大学学报(自然科学版),2022,41(5):542-546.
[6] Qu J,Yu J,Zhong S,et al.The presence of clear cell glands around the ovarian endometrioid cyst has an association with clear cell carcinoma[J].Virchows Arch,2023,482(6):1021-1034.
[7] 晁辉,吕瑾,荆治,等.桂枝茯苓汤联合超声引导下介入治疗卵巢巧克力囊肿疗效及对E_2、LH、FSH的影响[J].中华中医药学刊,2022,40(11):247-249.
[8] 龚曌,刘明辉.超声引导介入治疗卵巢子宫内膜异位囊肿的疗效评估[J].中国医学物理学杂志,2018,35(3):292-295.
[9] 伍婷婷,刘萍,唐可,等.腹腔镜卵巢囊肿切除术前后患者血清CA199、HE4水平及与性激素变化关系[J].中国计划生育学杂志,2021,29(10):2112-2116.
[10] 黎灿强,徐乐,梁鸿毅,等.超声引导精索阻滞下F4.8可视肾镜治疗附睾良性肿物的疗效分析[J].天津医药,2021,49(12):1303-1307. |
|
|
|
2024, Vol. 30 
